InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ANI PHARMACEUTICALS INC

ANIP Clue Score55
United States Fiscal year ends December CIK 0001023024 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

18
Insider
Date
Role
Action
Shares
Price
Amount
Stephen P. Carey
2 Jul 2026
SVP & CFO
Sold after exercise
3,313
$86.00
$284.92K
Stephen P. Carey
5 Jun 2026
SVP & CFO
Sold after exercise
3,312
$80.00
$264.96K
Stephen P. Carey
5 Mar 2026
SVP & CFO
Sold after exercise
4,000
$75.56
$302.24K
Stephen P. Carey
5 Mar 2026
SVP & CFO
Sold after exercise
3,312
$75.42
$249.79K
Stephen P. Carey
12 Aug 2025
SVP & CFO
Sold after exercise
50,000
$86.07
$4.30M
Ori Gutwerg
5 Mar 2025
SVP, Generics
Sold after exercise
5,084
$60.00
$305.04K
Ori Gutwerg
5 Mar 2025
SVP, Generics
Sold after exercise
300
$60.03
$18.01K
Nikhil Lalwani
26 Nov 2024
President & CEO
Sold after exercise
3,481
$58.30
$202.94K
Nikhil Lalwani
26 Nov 2024
President & CEO
Sold after exercise
30,000
$57.95
$1.74M
James G. Marken
23 Aug 2023
SVP Ops & Prod Dev
Sold after exercise
3,932
$63.00
$247.72K
Ori Gutwerg
23 Aug 2023
SVP, Generics
Sold after exercise
2,059
$62.39
$128.46K
Ori Gutwerg
23 Aug 2023
SVP, Generics
Sold after exercise
13,502
$62.39
$842.39K
Nikhil Lalwani
15 Aug 2023
President & CEO
Sold after exercise
11,616
$61.13
$710.09K
Arthur Przybyl
19 Mar 2019
President and CEO
Sold after exercise
2,823
$63.51
$179.29K
Arthur Przybyl
18 Mar 2019
President and CEO
Sold after exercise
24,802
$63.53
$1.58M
Robert W Schrepfer
13 Mar 2019
SVP - New Bus Dev & Spec Sales
Sold after exercise
4,651
$64.43
$299.65K
Robert W Schrepfer
12 Mar 2019
SVP - New Bus Dev & Spec Sales
Sold after exercise
1,503
$64.50
$96.94K
Robert W Schrepfer
12 Mar 2019
SVP - New Bus Dev & Spec Sales
Sold after exercise
5,642
$64.44
$363.58K
Showing 250 of 268 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 443
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 127
Sales straight out of an exercise 26
Sales at will 89
Transactions with no price 0
Shares from compensation/vesting 4,962,594
Sales filed before the plan box existed 37
History held since 29 Sep 2006